Nuo Therapeutics, Inc.

AURX · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$2,324-$3,171-$3,172-$19
Dep. & Amort.$96$105$74$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$57$22$9$14
Change in WC-$37-$299-$471$6
Other Non-Cash-$24$176-$146-$13,936,000
Operating Cash Flow-$2,232-$3,168-$3,706-$13
Investing Activities
PP&E Inv.-$155-$7-$60$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$155-$7-$60$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$1,500$1,998$4,458$1,373
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$242$0$0$1,373,092,000
Financing Cash Flow$1,742$1,998$4,458$1,373,092,000
Forex Effect$0$0$0$0
Net Chg. in Cash-$645-$1,178$692-$13
Supplemental Information
Beg. Cash$929$2,106$1,415$161
End Cash$284$929$2,106$148
Free Cash Flow-$2,387-$3,175-$3,766-$13